Keyword: Dr. Axel C. Heitmann

News

Lanxess gets more ambitious, announces new mid-term goal

19.09.2012 - Lanxess has announced a new mid-term goal for its leading earnings indicator - EBITDA pre exceptionals - of EUR 1.8 billion in 2018. The German specialty chemicals company is...